MicroPort Endovascular MedTech Ltd - Asset Resilience Ratio
MicroPort Endovascular MedTech Ltd (688016) has an Asset Resilience Ratio of 18.30% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See MicroPort Endovascular MedTech Ltd (688016) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2025–2025)
This chart shows how MicroPort Endovascular MedTech Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see MicroPort Endovascular MedTech Ltd (688016) total assets.
Liquid Assets Composition Over Time
This chart breaks down MicroPort Endovascular MedTech Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read 688016 liabilities breakdown for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥906.83 Million | 18.3% |
| Total Liquid Assets | CN¥906.83 Million | 18.30% |
Asset Resilience Insights
- Good Liquidity Position: MicroPort Endovascular MedTech Ltd maintains a healthy 18.30% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
MicroPort Endovascular MedTech Ltd Industry Peers by Asset Resilience Ratio
Compare MicroPort Endovascular MedTech Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medtronic plc
SA:MDTC34 |
Medical Devices | 7.82% |
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Medartis Holding AG
SW:MED |
Medical Devices | 0.00% |
|
Xiangyu Medical Co. Ltd. A
SHG:688626 |
Medical Devices | 1.53% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Beijing Chunlizhengda Medical Instruments Co Ltd
SHG:688236 |
Medical Devices | 25.01% |
|
Mediantechn
PA:ALMDT |
Medical Devices | 0.45% |
Annual Asset Resilience Ratio for MicroPort Endovascular MedTech Ltd (2025–2025)
The table below shows the annual Asset Resilience Ratio data for MicroPort Endovascular MedTech Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 2.16% | CN¥100.37 Million ≈ $14.69 Million |
CN¥4.64 Billion ≈ $679.15 Million |
-- |
About MicroPort Endovascular MedTech Ltd
Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, manufacturing, sale, and services of aortic, peripheral vascular, and tumor intervention devices in China and internationally. The company offers Fontus, a branched stent graft system in surgical operation; CRONUS, a stent graft system in surgical operation; Hector, a multi-branch thoracic stent graft syste… Read more